 |
 |
 |
 |
||||
 |
 |
 |
 |
 |
 |
|
|
|
|
 |
 |
 |
 |
|
|
Avera is a private company, funded and supported by a distinguished and experienced group of leading healthcare investors. In addition to venture financing, Avera has received funds from the Stanley Medical Research Institute, to support the development of AV965.
Please visit
our investors' websites for additional information:
| Aisling Capital | www.aislingcapital.com |
| SV Life Sciences | www.svlifesciences.com |
| Frazier & Company | www.frazierco.com |
| Bay City Capital | www.baycitycapital.com |
| H.I.G. Ventures | www.higventures.com |
| Aberdare Ventures | www.aberdare.com |
| Vivo Ventures | www.bioasia.com |
| Montreux Equity Partners | www.montreuxequity.com |
| InterWest Partners | www.interwest.com |
| Split Rock Partners | www.splitrockpartners.com |
| Windamere Venture Partners | www.windamerevp.com |
Home
| Company Profile | Strategy
| Therapeutic Interests | Product
Pipeline | Business Development | Contact
Us
© 2002-2006 Avera Pharmaceuticals, Inc.